DALE MEDICAL PRODUCTS, INC.

DALE MEDICAL PRODUCTS, INC. specializes in the manufacturing and supply of medical devices and related healthcare products, operating within the medical equipment and supplies sector under NAICS 339113. The company’s core capabilities center on the design, production, and quality-controlled fabrication of Class I and II medical devices, with an emphasis on sterile packaging, material compliance, and adherence to FDA 21 CFR Part 820 quality system regulations. Their technical expertise includes precision molding, assembly of disposable medical components, and validation of manufacturing processes to meet ISO 13485 standards. While specific product types cannot be confirmed from available data, their operational focus suggests specialization in single-use clinical tools, diagnostic accessories, or patient-care disposables requiring high-reliability production environments. Differentiators likely include tight process controls, documentation rigor, and supply chain traceability critical for regulated medical markets. No agency award history is available to characterize specific government relationships or programmatic engagements. Consequently, no patterns of interaction with federal departments such as DOD, VA, or HHS can be inferred. The company’s primary industry focus is the medical device manufacturing sector, where they operate as a contract producer for regulated healthcare products. Their market positioning aligns with suppliers supporting institutional procurement channels, including hospitals, federal medical logistics networks, and defense health systems—though direct contract evidence is not documented. DALE MEDICAL PRODUCTS, INC. is a small business structured as a 2L entity, headquartered in Franklin, Massachusetts. The company holds no active government certifications such as 8(a), HUBZone, or WOSB. Its geographic presence is limited to its Massachusetts facility, and its government market positioning is defined by its capacity to deliver compliant, high-volume medical device components to federal supply chains, pending successful qualification under applicable regulatory and procurement frameworks.